http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11591353-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d7cb7a0f4d450416a7ac8f0955a702e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-942
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5728
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572
filingDate 2022-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2023-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d4427a4e3c0e369afb5c3b5fe0a4658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8558a50dd045cab526ae204ebb497a51
publicationDate 2023-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11591353-B2
titleOfInvention Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
abstract The present application relates to psilocin derivatives of Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptor in a cell.
priorityDate 2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020157569-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3202675-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11242318-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020041329-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010012397-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022000091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020245133-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-307719-B6
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021108911-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022038171-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022120181-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010012396-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7429575-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016205304-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021403425-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021089873-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021363104-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018021326-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022177427-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021158888-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021226092-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324762-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019073379-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022038170-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022110956-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022110955-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2934061-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7572776-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009007421-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020181194-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011019738-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-990092-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021116503-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7776844-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000534-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3078214-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11292765-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016161138-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006047032-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021234608-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-981192-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022119346-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID479274284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13566983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID479274235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156821143

Total number of triples: 76.